I. Kudaba : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (12)
Les plus populaires
Liste
- Liste
- Tableau

1

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Mok, Tony S K, Wu, Yi-Long, Kudaba, Iveta, Kowalski, Dariusz M, Cho, Byoung Chul, Turna, Hande Z, Castro, Gilberto, Srimuninnimit, Vichien, Laktionov, Konstantin K, Bondarenko, Igor, Kubota, Karou, Lu

Journal:

Lancet (London, England)

Année:

2019

Langue:

english

Fichier:

PDF, 1.18 MB

english, 2019

2

LBA-002Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study

Tabernero, J, Van Cutsem, E, Bang, Y, Fuchs, C, Wyrwicz, L, Lee, K, Kudaba, I, Garrido, M, Chung, H, Castro Salguero, H, Mansoor, W, Braghiroli, M, Goekkurt, E, Chao, J, Wainberg, Z, Kher, U, Shah, S,

Journal:

Annals of Oncology

Année:

2019

Langue:

english

Fichier:

PDF, 111 KB

english, 2019

3

The Utility of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography in the Investigation of Patients with Disseminated Carcinoma of Unknown Primary Origin

Clare L. Scott, Iveta Kudaba, Josephine M. Stewart, Rodney J. Hicks, Danny Rischin

Journal:

Molecular Imaging and Biology

Année:

2005

Langue:

english

Fichier:

PDF, 256 KB

english, 2005

4

PP-8-21 Response to neoadjuvant chemotheraphy in locally advanced breast cancer

G. Purkalne, I. Kudaba

Journal:

European Journal of Cancer

Année:

1996

Langue:

english

Fichier:

PDF, 177 KB

english, 1996

5

Absence of pharmacokinetic drug–drug interaction of pertuzumab with trastuzumab and docetaxel

Cortés, Javier, Swain, Sandra M., Kudaba, Iveta, Hauschild, Maik, Patel, Taral, Grincuka, Elza, Masuda, Norikazu, McNally, Virginia, Ross, Graham, Brewster, Mike, Marier, Jean-François, Trinh, My My,

Journal:

Anti-Cancer Drugs

Année:

2013

Langue:

english

Fichier:

PDF, 517 KB

english, 2013

6

Renal Cell Carcinoma – How Can We Predict its Outcomes in Clinical Practice?

Vaivode, Ieva, Lietuvietis, Vilnis, Hegmane, Alinta, Kudaba, Iveta

Journal:

Acta Chirurgica Latviensis

Année:

2013

Langue:

english

Fichier:

PDF, 104 KB

english, 2013

7

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial

Markóczy, Zsolt, Sárosi, Veronika, Kudaba, Iveta, Gálffy, Gabriella, Turay, Ülkü Yilmaz, Demirkazik, Ahmet, Purkalne, Gunta, Somfay, Attila, Pápai-Székely, Zsolt, Rásó, Erzsébet, Ostoros, Gyula

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 587 KB

english, 2018

8

PS1 Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS ≥1%

Lopes, G., Wu, Y., Kudaba, I., Kowalski, D., Cho, B., Turna, H., De Castro, G., Srimuninnimit, V., Laktionov, K., Bondarenko, I., Kubota, K., Lubiniecki, G., Zhang, J., Kush, D., Mok, T.

Journal:

Journal of Thoracic Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 157 KB

english, 2018

9

102OFinal analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

Mok, T S K, Wu, Y-L, Kudaba, I, Kowalski, D M, Cho, B C, Turna, H Z, de Castro, G, Srimuninnimit, V, Laktionov, K K, Bondarenko, I, Kubota, K, Caglevic, C, Karaszewska, B, Dang, T, Yin, L, Penrod, J,

Journal:

Annals of Oncology

Année:

2019

Fichier:

PDF, 112 KB

2019

10

125OPembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study

Chung, H C, Bang, Y-J, Tabernero, J, Van Cutsem, E, Fuchs, C S, Wyrwicz, L, Lee, K-W, Kudaba, I, Garrido, M, Castro, H, Mansoor, W, Braghiroli, M I, Goekkurt, E, Chao, J, Wainberg, Z A, Kher, U, Shah,

Journal:

Annals of Oncology

Année:

2019

Fichier:

PDF, 101 KB

2019

11

Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer

Shitara, Kohei, Van Cutsem, Eric, Bang, Yung-Jue, Fuchs, Charles, Wyrwicz, Lucjan, Lee, Keun-Wook, Kudaba, Iveta, Garrido, Marcelo, Chung, Hyun Cheol, Lee, Jeeyun, Castro, Hugo Raul, Mansoor, Wasat, B

Journal:

Année:

2020

Fichier:

PDF, 487 KB

2020

12

Pharmacokinetics (PK) of Pertuzumab (P) With Trastuzumab (T) and Docetaxel (D) in HER2-Positive First-Line Metastatic Breast Cancer (MBC): Results From the Phase III Trial Cleopatra

Cortes, J., Swain, S., Kudaba, I., Hauschild, M., Patel, T., Grincuka, E., Masuda, N., McNally, V., Visich, J., Baselga, J.

Journal:

Annals of Oncology

Année:

2012

Fichier:

PDF, 90 KB

2012